These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22607214)
21. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Takami Y; Horio T; Iwashima Y; Takiuchi S; Kamide K; Yoshihara F; Nakamura S; Nakahama H; Inenaga T; Kangawa K; Kawano Y Am J Kidney Dis; 2004 Sep; 44(3):420-8. PubMed ID: 15332214 [TBL] [Abstract][Full Text] [Related]
22. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study. de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205 [TBL] [Abstract][Full Text] [Related]
23. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients. Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941 [TBL] [Abstract][Full Text] [Related]
24. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up. Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955 [TBL] [Abstract][Full Text] [Related]
25. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease]. Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382 [TBL] [Abstract][Full Text] [Related]
26. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure. Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522 [TBL] [Abstract][Full Text] [Related]
27. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742 [TBL] [Abstract][Full Text] [Related]
28. Natriuretic peptides in unstable coronary artery disease. Jernberg T; James S; Lindahl B; Johnston N; Stridsberg M; Venge P; Wallentin L Eur Heart J; 2004 Sep; 25(17):1486-93. PubMed ID: 15342167 [TBL] [Abstract][Full Text] [Related]
29. How does volume status affect BNP and troponin levels as markers of cardiovascular status in peritoneal dialysis? Garg R; Singh A; Khaja A; Martin A; Aggarwal K Congest Heart Fail; 2009; 15(5):240-4. PubMed ID: 19751426 [TBL] [Abstract][Full Text] [Related]
30. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247 [TBL] [Abstract][Full Text] [Related]
31. Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker? Rosner MH Kidney Int; 2007 Mar; 71(6):481-3. PubMed ID: 17344896 [TBL] [Abstract][Full Text] [Related]
32. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308 [TBL] [Abstract][Full Text] [Related]
35. An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients. van de Pol AC; Frenken LA; Moret K; Baumgarten R; van der Sande FM; Beerenhout CM; Kooman JP; Leunissen KM Hemodial Int; 2007 Jan; 11(1):51-61. PubMed ID: 17257357 [TBL] [Abstract][Full Text] [Related]
36. Natriuretic peptides and the dialysis patient. Suresh M; Farrington K Semin Dial; 2005; 18(5):409-19. PubMed ID: 16191182 [TBL] [Abstract][Full Text] [Related]
37. Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients. Carr SJ; Bavanandan S; Fentum B; Ng L Clin Sci (Lond); 2005 Jul; 109(1):75-82. PubMed ID: 15743271 [TBL] [Abstract][Full Text] [Related]
38. [Clinical utility of the cardiac markers BNP and NT-proBNP]. Buchner S; Riegger G; Luchner A Acta Med Austriaca; 2004; 31(4):144-51. PubMed ID: 15732251 [TBL] [Abstract][Full Text] [Related]
39. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041 [TBL] [Abstract][Full Text] [Related]
40. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Jacobs LH; van de Kerkhof JJ; Mingels AM; Passos VL; Kleijnen VW; Mazairac AH; van der Sande FM; Wodzig WK; Konings CJ; Leunissen KM; van Dieijen-Visser MP; Kooman JP Nephrol Dial Transplant; 2010 Jan; 25(1):243-8. PubMed ID: 19692417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]